The Huntsman Cancer Institute (HCI) is a designated research unit of the University of Utah. It was formed in July 1994, from the previous, NCI-designate Utah Regional Cancer Center, with major funding provided in late 1995 by the Jon M. Huntsman family, through the Huntsman Cancer Foundation. The mission of the HCI is the translation of molecular and genetic discoveries in the mechanisms of carcinogenesis into clinically effective diagnostics and therapies. The Institute's primary focus on understanding and intervening in the earliest events in the carcinogenesis pathways, at the level of the cancer precursor cell, leads to a strong emphasis on identifying the inherited components of cancer predisposition, as these components are often among the earliest steps in the carcinogenesis pathways. This orientation stem's from the University's history in the development and use of molecular genetic tools for mapping of human disease genes, in particular the genes that predispose to cancer. The Cancer Center is organized into six programs; three basic science programs-Cell Response and Regulation, Molecular Pharmacology, and Nuclear Control of Cell Growth and Differentiation and three disease-focused programs-Brain, Colon and Hematology. Fourteen research resource facilities service these programs; seven of these are new facilities established since the last competitive renewal. In this application, we are requesting funds in the amount of $1.2 million, 46 percent of which will support shared resource facilities, 26 percent professional and administrative personnel, and 25 percent for development. The leadership of the HCI and the University of Utah are committed to the efforts of the Cancer Center. Raymond L. White, Ph.D., is the Executive Director of the HCI and the Principal Investigator of the Cancer Center Support Grant. His laboratory has been heavily involved in studies of genes that predispose to cancer for nearly two decades. Furthermore, the ice President and Dean of the Health Sciences Center at the University provides strong institutional support in the form of space and core resources for the institute's scientific endeavors.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA042014-14
Application #
6375744
Study Section
Subcommittee G - Education (NCI)
Program Officer
Ptak, Krzysztof
Project Start
1986-07-01
Project End
2004-04-30
Budget Start
2001-08-03
Budget End
2002-04-30
Support Year
14
Fiscal Year
2001
Total Cost
$1,238,364
Indirect Cost
Name
University of Utah
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Barrott, Jared J; Illum, Benjamin E; Jin, Huifeng et al. (2018) Paracrine osteoprotegerin and ?-catenin stabilization support synovial sarcomagenesis in periosteal cells. J Clin Invest 128:207-218
Sample, Danielle C; Samadder, N Jewel; Pappas, Lisa M et al. (2018) Variables affecting penetrance of gastric and duodenal phenotype in familial adenomatous polyposis patients. BMC Gastroenterol 18:115
Delker, Don A; Wood, Austin C; Snow, Angela K et al. (2018) Chemoprevention with Cyclooxygenase and Epidermal Growth Factor Receptor Inhibitors in Familial Adenomatous Polyposis Patients: mRNA Signatures of Duodenal Neoplasia. Cancer Prev Res (Phila) 11:4-15
Madsen, Michael J; Knight, Stacey; Sweeney, Carol et al. (2018) Reparameterization of PAM50 Expression Identifies Novel Breast Tumor Dimensions and Leads to Discovery of a Genome-Wide Significant Breast Cancer Locus at 12q15. Cancer Epidemiol Biomarkers Prev 27:644-652
Trott, Daniel W; Henson, Grant D; Ho, Mi H T et al. (2018) Age-related arterial immune cell infiltration in mice is attenuated by caloric restriction or voluntary exercise. Exp Gerontol 109:99-107
Wu, Yelena P; Parsons, Bridget G; Mooney, Ryan et al. (2018) Barriers and Facilitators to Melanoma Prevention and Control Behaviors Among At-Risk Children. J Community Health 43:993-1001
Zabriskie, Matthew S; Antelope, Orlando; Verma, Anupam R et al. (2018) A novel AGGF1-PDGFRb fusion in pediatric T-cell acute lymphoblastic leukemia. Haematologica 103:e87-e91
Wolff, Roger K; Hoffman, Michael D; Wolff, Erica C et al. (2018) Mutation analysis of adenomas and carcinomas of the colon: Early and late drivers. Genes Chromosomes Cancer 57:366-376
Hellwig, Sabine; Nix, David A; Gligorich, Keith M et al. (2018) Automated size selection for short cell-free DNA fragments enriches for circulating tumor DNA and improves error correction during next generation sequencing. PLoS One 13:e0197333
Fleming, Aaron M; Zhu, Judy; Ding, Yun et al. (2018) Human DNA Repair Genes Possess Potential G-Quadruplex Sequences in Their Promoters and 5'-Untranslated Regions. Biochemistry 57:991-1002

Showing the most recent 10 out of 1193 publications